Dr. Ahmad Masri and Dr. C Michael Gibson discuss outpatient worsening heart failure in transthyretin amyloid cardiomyopathy in the Attribute-CM trial

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.